BRPI0415966A - combinações compreendendo antagonistas do receptor ampa para tratamento de esquizofrenia - Google Patents
combinações compreendendo antagonistas do receptor ampa para tratamento de esquizofreniaInfo
- Publication number
- BRPI0415966A BRPI0415966A BRPI0415966-7A BRPI0415966A BRPI0415966A BR PI0415966 A BRPI0415966 A BR PI0415966A BR PI0415966 A BRPI0415966 A BR PI0415966A BR PI0415966 A BRPI0415966 A BR PI0415966A
- Authority
- BR
- Brazil
- Prior art keywords
- combinations
- treatment
- schizophrenia
- ampa receptor
- receptor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMBINAçõES COMPREENDENDO ANTAGONISTAS DO RECEPTOR AMPA PARA TRATAMENTO DE ESQUIZOFRENIA". A presente invenção refere-se a combinações adequadas para o tratamento de distúrbios psiquiátricos/neurológicos, em particular esquizofrenia. As combinações compreendem pelo menos um antagonista do receptor AMPA e pelo menos um composto selecionado do grupo que consiste em (a) drogas antiepilépticas selecionadas de barbituratos e derivados dos mesmos, benzodiazepinas, carboxamidas, hidantoínas, succinimidas, ácido valpróico e outros derivados de ácidos graxos e outras drogas antiepilépticas, (b) antipsicóticos convencionais e (c) antipsicóticos atípicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0325175.8A GB0325175D0 (en) | 2003-10-28 | 2003-10-28 | Organic compounds |
PCT/EP2004/012150 WO2005049040A1 (en) | 2003-10-28 | 2004-10-27 | Combinations comprising ampa receptor antagonists for the treatment of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0415966A true BRPI0415966A (pt) | 2007-01-23 |
Family
ID=29725529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0415966-7A BRPI0415966A (pt) | 2003-10-28 | 2004-10-27 | combinações compreendendo antagonistas do receptor ampa para tratamento de esquizofrenia |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070082873A1 (pt) |
EP (1) | EP1682157A1 (pt) |
JP (1) | JP2007509883A (pt) |
CN (1) | CN1874779A (pt) |
AU (1) | AU2004290890B2 (pt) |
BR (1) | BRPI0415966A (pt) |
CA (1) | CA2541293A1 (pt) |
GB (1) | GB0325175D0 (pt) |
MX (1) | MXPA06004780A (pt) |
WO (1) | WO2005049040A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008041118A2 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
CA2781685C (en) | 2009-12-11 | 2018-09-04 | Autifony Therapeutics Limited | Imidazolidinedione derivatives |
PL2649066T3 (pl) | 2010-12-06 | 2017-04-28 | Autifony Therapeutics Limited | Pochodne hydantoiny przydatne jako inhibitory KV3 |
BR112014028718A2 (pt) | 2012-05-22 | 2017-06-27 | Autifony Therapeutics Ltd | derivados de hidantoína como inibidores de kv3 |
WO2013175215A1 (en) | 2012-05-22 | 2013-11-28 | Autifony Therapeutics Limited | Triazoles as kv3 inhibitors |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424179A3 (en) * | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
SK282548B6 (sk) * | 1996-10-24 | 2002-10-08 | Novartis Ag | Substituované aminoalkánfosfónové kyseliny, spôsob ich prípravy, farmaceutické prostriedky, ktoré ich obsahujú, a ich použitie |
WO1999021422A1 (en) * | 1997-10-27 | 1999-05-06 | Cortex Pharmaceuticals, Inc. | Treatment of schizophrenia with ampakines and neuroleptics |
US6420369B1 (en) * | 1999-05-24 | 2002-07-16 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating dementia |
EP1187604A4 (en) * | 1999-05-28 | 2004-02-11 | Jeffrey Berlant | CONNECTIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS FAILURES |
US6191117B1 (en) * | 2000-07-10 | 2001-02-20 | Walter E. Kozachuk | Methods of producing weight loss and treatment of obesity |
WO2003066039A1 (en) * | 2002-02-08 | 2003-08-14 | Abbott Laboratories | Combination therapy for treatment of schizophrenia |
TW200403066A (en) * | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
DE10332487A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen |
DE10332473A1 (de) * | 2003-07-16 | 2005-02-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von Epilepsie |
-
2003
- 2003-10-28 GB GBGB0325175.8A patent/GB0325175D0/en not_active Ceased
-
2004
- 2004-10-27 WO PCT/EP2004/012150 patent/WO2005049040A1/en active Application Filing
- 2004-10-27 US US10/577,196 patent/US20070082873A1/en not_active Abandoned
- 2004-10-27 AU AU2004290890A patent/AU2004290890B2/en not_active Ceased
- 2004-10-27 BR BRPI0415966-7A patent/BRPI0415966A/pt not_active IP Right Cessation
- 2004-10-27 CN CNA2004800316615A patent/CN1874779A/zh active Pending
- 2004-10-27 EP EP04790923A patent/EP1682157A1/en not_active Withdrawn
- 2004-10-27 CA CA002541293A patent/CA2541293A1/en not_active Abandoned
- 2004-10-27 JP JP2006537176A patent/JP2007509883A/ja active Pending
- 2004-10-27 MX MXPA06004780A patent/MXPA06004780A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2541293A1 (en) | 2005-06-02 |
US20070082873A1 (en) | 2007-04-12 |
AU2004290890B2 (en) | 2008-10-30 |
JP2007509883A (ja) | 2007-04-19 |
AU2004290890A1 (en) | 2005-06-02 |
EP1682157A1 (en) | 2006-07-26 |
GB0325175D0 (en) | 2003-12-03 |
WO2005049040A1 (en) | 2005-06-02 |
CN1874779A (zh) | 2006-12-06 |
MXPA06004780A (es) | 2006-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
EA200100203A1 (ru) | Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов | |
MXPA05010859A (es) | Antagonistas mchr1 heterociclicos. | |
MEP45308A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
CR9389A (es) | Compuestos de imidazopiridazina | |
EP1423370A4 (en) | COMPOUNDS BINDING TO THE NUCLEAR FXR-NR1H4 RECEPTOR | |
TW200517388A (en) | Thiazole derivatives as cannabinoid receptor modulators | |
EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
MA27561A1 (fr) | Derives d'aminoindazoles et leur utilisation comme inhibiteurs de kinases | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
WO2002000623A3 (en) | Aryl fused substituted 4-oxy-pyridines | |
NO20064238L (no) | Imidazolinderivater med CB1 agonistlsk aktivitet | |
ES2171723T3 (es) | 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2. | |
ATE377602T1 (de) | Morphinanderivate und ihre medizinische anwendung | |
EA200501595A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
BR0013311A (pt) | Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor | |
CR9622A (es) | Derivados de pirazolo[3,4-d]azepina como antagonistas de histamina h3 | |
UA84896C2 (ru) | Производные гидронопола как агонисты человеческих рецепторов orl1 | |
EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
EA200501593A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
TW200519101A (en) | Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
BRPI0415966A (pt) | combinações compreendendo antagonistas do receptor ampa para tratamento de esquizofrenia | |
EE05182B1 (et) | Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |